Home / Market News / $LEAP

$LEAP news and market catalysts

The 1 most recent market catalysts affecting $LEAP, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

1 catalysts 0 high impact 1 bullish 0 bearish Biotechnology

Aug 12, 2026 Corporate Catalyst Bullish Impact 75

Cypherpunk's Leap Therapeutics Announces Publication Of Phase 2 DeFianCe Sirexatamab Data In Clinical Cancer Research; Study Missed ITT PFS Primary Endpoint But Showed DKK1-High Benefit, Median OS Not Reached vs. 14.4 Months

The headline indicates that Leap Therapeutics' drug, Sirexatamab, missed its primary endpoint (ITT PFS) in a Phase 2 study, which is generally a significant negative for a biotechn…

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.